Aurobindo Pharma enters licensing pact with US biotech COVAXX for manufacture, sale of COVID-19 vaccine

Aurobindo Pharma enters licensing pact with US biotech COVAXX for manufacture, sale of COVID-19 vaccine COVAXX is currently conducting a Phase 1 clinical trial for the vaccine candidate. 

No comments:

Post a Comment